CAS: 1455-13-6; Methanol-D

该化合物是乙醇的一个稳定的同位素变异物,氢原子由氢原子被氢的更重的同位素-取代,其化学配方为CD3OH,并经常用于各种科学应用,特别是核磁共振(NMR)光谱学,由于它独特的同位素特性,可以用作溶剂;在NMR中存在对化学变化进行改变的除子,以便更清楚地分析分子结构;乙醇-d是一种无色,挥发性液体,其物理外观与普通甲醇相似,但具有不同的物理和化学特性,例如沸点和密度更高;还用于动能研究,以及脱化化合物合成,用于有机化学和药物的各种应用;在处理乙醇-d时,必须采取安全防范措施,因为乙醇-d是易燃的,如果浸入或吸入,则具有毒性.

结构式图片

欧盟法规

ECHA物质C&L通报REACH预注册

上下游产品

CAS号14524-92-6 Methyl rhenium ... | CAS号64724-26-1 methaneselenini... | CAS号67-56-1 甲醇 | CAS号408501-65-5 phenyl 3-chloro... | CAS号50-00-0 甲醛 | CAS号74-87-3 氯甲烷 | CAS号1109286-34-1 (CH3)2(C3HN2Ge)... | CAS号3585-32-8 1,3-DIMETHYLTRIAZENE | CAS号131-11-3 邻苯二甲酸二甲酯; 避蚊酯 | CAS号74-83-9 溴甲烷 | CAS号598-99-2 三氯乙酸甲酯 | CAS号34322-11-7 hydrogen peroxide | CAS号7789-20-0 重水 | CAS号6909-54-2 deuterium peroxide | CAS号14940-63-7 deuterium hydro... | CAS号67-56-1 甲醇 | CAS号925-93-9 氘代乙醇-D1 | CAS号38050-71-4 8-甲氧基-9-硼杂双环[3.... | CAS号21300-54-9 乙酸甲酯-D3 | CAS号19901-15-6 乙醛-2,2,2-d3

合成工艺路线路线简述

    邻苯二甲酸二甲酯置于重水,Sodium Methylate体系中,化学反应生成氘代甲醇-D
    参考文献:Mozingo; Folkers,Chemistry Of Penicillin
    标题:Mozingo; Folkers,Chemistry Of Penicillin

    海关参考信息

    专利信息


    专利号:WO-2024201393-A1
    优先权日:2023-03-29
    标 题:Methods for the synthesis of nucleoside analogues and nucleosides analogues derived therefrom
    发明人:BRITTON ROBERT; Muir Garrett; ANKETELL MATTHEW JAMES; HUXLEY COHAN; BAIKABI SUPING
    权利人:UNIV FRASER SIMON
    摘要:The present invention relates to methods for the synthesis of nucleoside analogues. More specifically, the present invention relates to methods for the synthesis of C4' substituted nucleoside analogues via the reaction of a soft nucleophile with a halohydrin ketone.

    专利号:US-6624294-B2
    优先权日:1999-01-08
    标 题:Regioselective synthesis of 2′-O-modified nucleosides
    发明人:KAWASAKI ANDREW M; FRASER ALLISTER S; MANOHARAN MUTHIAH; COOK P DAN; PRAKASH THAZHA P
    权利人:ISIS PHARMACEUTICALS INC
    摘要:Methods for the regioselective alkylation at the 2'-hydroxy position over the 3'-hydroxy position of nucleosides and nucleoside analogs, forming 2'-O-ester modified compounds, are disclosed. Reduction and derivatization of the 2'-O-ester provides 2'-O-modified nucleosides and nucleoside analogs useful for the synthesis of oligomeric compounds having improved hybridization affinity and nuclease resistance.

    专利号:US-9388147-B2
    优先权日:2009-11-13
    标题 :Selective sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
    发明人:MARTINBOROUGH ESTHER; BOEHM MARCUS F; YEAGER ADAM RICHARD; TAMIYA JUNKO; HUANG LIMING; BRAHMACHARY ENUGURTHI; MOORJANI MANISHA; TIMONY GREGG ALAN; BROOKS JENNIFER L; PEACH ROBERT; SCOTT FIONA LORRAINE; HANSON MICHAEL ALLEN
    权利人:RECEPTOS INC; CELGENE INTERNAT II SÃ?RL
    摘要:Compounds that selectively modulate the sphingosine 1 phosphate receptor are provided including compounds which modulate subtype 1 of the S1P receptor. Methods of chiral synthesis of such compounds are provided. Uses, methods of treatment or prevention and methods of preparing inventive compositions including inventive compounds are provided in connection with the treatment or prevention of diseases, malconditions, and disorders for which modulation of the sphingosine 1 phosphate receptor is medically indicated.

    专利号:WO-2005103035-A1
    优先权日:2004-04-23
    标题:Modified fischer indole synthesis of eletriptan
    发明人:ASHCROFT CHRISTOPHER PAUL
    权利人:PFIZER LTD; ASHCROFT CHRISTOPHER PAUL; PFIZER
    摘要:The present invention relates to a new process for the preparation of eletriptan (I), or its enantiomer comprising a modified Fischer indole synthesis, namely the reaction of a compound of formula (II), wherein R1 is a suitable hydrazine protecting group, with a compound of formula (III) wherein R2 is an aldehyde group (-CHO) or the functional equivalent thereof.

    专利号:US-9394264-B2
    优先权日:2009-11-13
    标 题:Sphingosine 1 phosphate receptor modulators and methods of chiral synthesis
    发明人:MARTINBOROUGH ESTHER; BOEHM MARCUS F; YEAGER ADAM RICHARD; TAMIYA JUNKO; HUANG LIMING; BRAHMACHARY ENUGURTHI; MOORJANI MANISHA
    权利人:RECEPTOS INC
    摘要:Compounds that selectively modulate the sphingosine 1 phosphate receptor are provided including compounds which modulate subtype 1 of the S1P receptor. Methods of chiral synthesis of such compounds are provided. Uses, methods of treatment or prevention and methods of preparing inventive compositions including inventive compounds are provided in connection with the treatment or prevention of diseases, malconditions, and disorders for which modulation of the sphingosine 1 phosphate receptor is medically indicated.

    专利号:US-3790555-A
    优先权日:1972-01-20
    标 题:Octapeptide derivative of gonadotropinreleasing hormone
    发明人:FLOURET G; COLE J
    权利人:ABBOTT LAB
    摘要:THE SYNTHESIS OF THE OCTAPEPTIDE TRP-SER-TYR-GLY-LEUARG-PRO-GLY-AMIDE CARRYING EASILY REMOVABLE PROTECTIVE GROUPS ON THE SER, TYR, ARG AND TRP MOIETIES IS DESCRIBED. THE NEW SYNTHESIS USES AS THE STARTING MATERIAL TWO TETRAPEPTIDE FRAGMENTS CARRYING EASILY REMOVABLE PROTECTIVE GROUPS. ONE OF THESE FRAGMENTS, TRP-SER-TYR-GLY-OH WITH SUITABLE PROTECTIVE GROUPS, ALSO IS A PART OF THE PRESENT INVENTION. AFTER COUPLING OF THE TWO FRAGMENTS, THE PROTECTIVE GROUP ON THE AMINO-N OF THE TRYPTOPHANE MOIETY IS REMOVED TO OBTAIN AN OCTAPEPTIDE CARRYING EASILY REMOVABLE PROTECTIVE GROUPS WHICH CAN BE RETAINED VHILE BULIDING UP THE MOLECULE TO THE DECAPEPTIDE CHAIN WHICH IS THE GONADOTROPIN-RELEASING HORMONE, AFTER REMOVAL OF THESE PROTECTIVE GROUPS.
    平顶山凯美威生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.chemiway.net
    企业联系电话:022-87601716;0375-7275566👤
    📞平顶山凯美威生物科技有限公司 ⚠️参考联系方式
    联系人:张经理
    电话:022-87601716;0375-7275566
    手机:13920326762
    传真:022-87072180;0375-7275558
    邮箱:yzhang@chemiway.net;sales@chemiway.net
    通信地址: 河南省平顶山市化工产业集聚区
    邮编: 467200
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:河南省平顶山市化工产业集聚区
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海冠屹化工有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.chenchem.cn
    企业联系电话:15900983188👤
    📞上海冠屹化工有限公司 ⚠️参考联系方式
    联系人:陈先生
    电话:15900983188
    手机:15900983188

    邮箱:chen@chenchem.com
    通信地址: 上海市金山区山阳镇浦卫公路16299弄13号5层;杭州办事处:杭州市西湖区文三西路333号会馆102
    邮编:
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市金山区山阳镇浦卫公路16299弄13号5层;杭州办事处:杭州市西湖区文三西路333号会馆102
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海亚兴生物医药科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.isotopemall.com
    企业联系电话:021-58956006,021-58950017👤
    📞上海亚兴生物医药科技有限公司 ⚠️参考联系方式
    联系人:段经理
    电话:021-58956006,021-58950017
    手机:15800617331
    传真:021-58956100
    邮箱:sales@langchem.com
    通信地址: 上海川沙新镇妙镜路1111弄恒越生活广场5号楼303室
    邮编: 201204
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海川沙新镇妙镜路1111弄恒越生活广场5号楼303室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Kantchev, E. A. B.; Organ, M. G., Science of Synthesis, (2009) 48, 18.
    摘要:Zaidlewicz, M.; Krzemiński, M. P.; Dzieleńdziak, A., Science of Synthesis, (2009) 48, 359.
    摘要:Kostikov, R.; Baird, M. S., Science of Synthesis, (2009) 48, 616.
    摘要:Bruffaerts, J.; Vasseur, A., Science of Synthesis Knowledge Updates, (2016) 2, 160.
    摘要:Bruffaerts, J.; Vasseur, A., Science of Synthesis Knowledge Updates, (2016) 2, 162.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知